| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.38 | 0.005 | 0.38 | Pim-1 kinase inhibitor | 0.225 0.011 CID_128685 | ||
| 0.42 | 0.065 | 0.5 | Histamine release inhibitor | 0.5 0.029 CID_128685 | CID_128685 | |
| 0.384 | 0.031 | 0.384 | Calcium channel activator | 0.239 0.16 CID_128685 | ||
| 0.41 | 0.092 | 0.41 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.407 0.095 CID_128685 | ||
| 0.337 | 0.026 | 0.337 | RNA-directed DNA polymerase inhibitor | 0.205 0.093 CID_128685 | ||
| 0.298 | 0.006 | 0.298 | MAP kinase 13 inhibitor | 0.231 0.014 CID_128685 | ||
| 0.367 | 0.077 | 0.367 | GABA C receptor rho-3 antagonist | 0.23 0.173 CID_128685 | ||
| 0.3 | 0.012 | 0.3 | TRKA antagonist | 0.232 0.022 CID_128685 | ||
| 0.296 | 0.011 | 0.296 | TRKB antagonist | 0.159 0.042 CID_128685 | ||
| 0.296 | 0.012 | 0.35 | MAP kinase 9 inhibitor | 0.35 0.008 CID_128685 | CID_128685 | |
| 0.279 | 0.004 | 0.279 | Protein kinase B beta inhibitor | 0.137 0.01 CID_128685 | ||
| 0.29 | 0.016 | 0.29 | Phosphodiesterase inhibitor | 0.215 0.03 CID_128685 | ||
| 0.292 | 0.018 | 0.292 | Tyrosine-protein kinase receptor antagonist | 0.226 0.032 CID_128685 | ||
| 0.233 | 0.006 | 0.233 | Pim-3 kinase inhibitor | 0.132 0.025 CID_128685 | ||
| 0.229 | 0.004 | 0.229 | Protein kinase B alpha inhibitor | 0.133 0.014 CID_128685 | ||
| 0.27 | 0.047 | 0.27 | Clk dual-specificity kinase inhibitor | 0.223 0.066 CID_128685 | ||
| 0.273 | 0.054 | 0.273 | DNA synthesis inhibitor | 0.172 0.166 CID_128685 | ||
| 0.248 | 0.034 | 0.248 | MAP kinase kinase 3 inhibitor | 0.208 0.1 CID_128685 | ||
| 0.266 | 0.057 | 0.266 | Pyruvate kinase inhibitor | 0.231 0.067 CID_128685 | ||
| 0.248 | 0.047 | 0.248 | CDC-like kinase 4 inhibitor | 0.231 0.053 CID_128685 | ||
| 0.228 | 0.027 | 0.228 | Ribosomal protein S6 kinase inhibitor | |||
| 0.203 | 0.008 | 0.203 | Phosphatidylinositol kinase inhibitor | 0.097 0.022 CID_128685 | ||
| 0.273 | 0.081 | 0.273 | Hypoxia-inducible factor 1 alpha inhibitor | 0.216 0.133 CID_128685 | ||
| 0.28 | 0.09 | 0.28 | Caspase 3 stimulant | 0.274 0.094 CID_128685 | ||
| 0.2 | 0.011 | 0.2 | Sphingosine 1-phosphate receptor 2 agonist | 0.127 0.044 CID_128685 | ||
| 0.225 | 0.037 | 0.225 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.232 | 0.047 | 0.232 | I kappa B kinase epsilon inhibitor | |||
| 0.194 | 0.013 | 0.194 | Gastric antisecretory | 0.119 0.044 CID_128685 | ||
| 0.186 | 0.008 | 0.186 | Phosphatidylinositol 3-kinase alpha inhibitor | 0.082 0.021 CID_128685 | ||
| 0.182 | 0.013 | 0.182 | Phosphodiesterase 7B inhibitor | 0.113 0.043 CID_128685 | ||
| 0.218 | 0.055 | 0.218 | LIM domain kinase 1 inhibitor | 0.164 0.085 CID_128685 | ||
| 0.167 | 0.005 | 0.167 | Phosphodiesterase 10A inhibitor | 0.101 0.01 CID_128685 | ||
| 0.167 | 0.005 | 0.167 | Phosphodiesterase X inhibitor | 0.101 0.01 CID_128685 | ||
| 0.207 | 0.048 | 0.207 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.195 0.053 CID_128685 | ||
| 0.165 | 0.009 | 0.165 | mTOR complex 1 inhibitor | 0.096 0.072 CID_128685 | ||
| 0.171 | 0.016 | 0.171 | Nitric-oxide synthase inhibitor | |||
| 0.188 | 0.033 | 0.188 | Protein kinase (CK1) delta inhibitor | 0.129 0.067 CID_128685 | ||
| 0.255 | 0.102 | 0.255 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.221 | 0.069 | 0.221 | MAP kinase kinase 2 inhibitor | |||
| 0.191 | 0.041 | 0.191 | Hexokinase inhibitor | 0.134 0.098 CID_128685 | ||
| 0.191 | 0.043 | 0.191 | Protein kinase (CK1) inhibitor | 0.13 0.083 CID_128685 | ||
| 0.153 | 0.008 | 0.153 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.05 0.048 CID_128685 | ||
| 0.185 | 0.045 | 0.185 | CDC-like kinase 1 inhibitor | 0.139 0.079 CID_128685 | ||
| 0.31 | 0.17 | 0.448 | MAP kinase 1 inhibitor | 0.448 0.078 CID_128685 | CID_128685 | |
| 0.209 | 0.074 | 0.209 | Nitric-oxide synthase stimulant | |||
| 0.167 | 0.033 | 0.167 | MAP kinase 12 inhibitor | 0.142 0.048 CID_128685 | ||
| 0.138 | 0.008 | 0.138 | Pim-2 kinase inhibitor | 0.057 0.034 CID_128685 | ||
| 0.214 | 0.088 | 0.214 | MAP-kinase-activated kinase 5 inhibitor | 0.181 0.13 CID_128685 | ||
| 0.198 | 0.074 | 0.198 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.156 0.135 CID_128685 | ||
| 0.14 | 0.018 | 0.14 | Toll-Like receptor 3 antagonist | |||
| 0.139 | 0.019 | 0.139 | Inducible nitric-oxide synthase inhibitor | |||
| 0.132 | 0.013 | 0.132 | mTOR complex 2 inhibitor | |||
| 0.175 | 0.056 | 0.175 | Cyclin-dependent kinase 8 inhibitor | 0.167 0.063 CID_128685 | ||
| 0.123 | 0.005 | 0.123 | Phosphodiesterase VIII inhibitor | 0.078 0.037 CID_128685 | ||
| 0.13 | 0.014 | 0.156 | Histone deacetylase SIRT1 stimulant | 0.156 0.008 CID_128685 | CID_128685 | |
| 0.13 | 0.014 | 0.156 | Histone deacetylase stimulant | 0.156 0.008 CID_128685 | CID_128685 | |
| 0.174 | 0.062 | 0.174 | Polo-like kinase-3 inhibitor | 0.13 0.11 CID_128685 | ||
| 0.136 | 0.028 | 0.136 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.1 0.046 CID_128685 | ||
| 0.151 | 0.044 | 0.151 | Heat shock protein 70 antagonist | 0.138 0.082 CID_128685 | ||
| 0.203 | 0.097 | 0.203 | Dyrk kinase inhibitor | 0.165 0.122 CID_128685 | ||
| 0.13 | 0.024 | 0.192 | Potassium channel (Voltage-sensitive) activator | 0.192 0.006 CID_128685 | CID_128685 | |
| 0.171 | 0.068 | 0.171 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.113 | 0.011 | 0.113 | 5 Hydroxytryptamine 3A antagonist | 0.081 0.03 CID_128685 | ||
| 0.116 | 0.014 | 0.116 | Biliverdin reductase inhibitor | 0.054 0.048 CID_128685 | ||
| 0.196 | 0.095 | 0.196 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.17 0.113 CID_128685 | ||
| 0.186 | 0.087 | 0.186 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.173 0.099 CID_128685 | ||
| 0.121 | 0.022 | 0.121 | Bromodomain-containing protein 2 inhibitor | 0.112 0.028 CID_128685 | ||
| 0.116 | 0.019 | 0.169 | Adenosine A3 receptor antagonist | 0.169 0.011 CID_128685 | CID_128685 | |
| 0.137 | 0.042 | 0.137 | MAP kinase kinase kinase inhibitor | 0.108 0.059 CID_128685 | ||
| 0.106 | 0.013 | 0.106 | 5 Hydroxytryptamine 3 agonist | |||
| 0.125 | 0.036 | 0.134 | Hedgehog signaling inhibitor | 0.134 0.031 CID_128685 | CID_128685 | |
| 0.116 | 0.028 | 0.116 | Glutamate (mGluR) antagonist | 0.09 0.041 CID_128685 | ||
| 0.169 | 0.083 | 0.169 | CDC-like kinase 2 inhibitor | 0.161 0.087 CID_128685 | ||
| 0.154 | 0.068 | 0.154 | CF transmembrane conductance regulator agonist | |||
| 0.1 | 0.014 | 0.1 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.11 | 0.024 | 0.11 | Adenosine A2 receptor antagonist | 0.085 0.032 CID_128685 | ||
| 0.201 | 0.115 | 0.201 | DNA damaging | 0.183 0.131 CID_128685 | ||
| 0.121 | 0.037 | 0.121 | DNA directed RNA polymerase inhibitor | |||
| 0.127 | 0.048 | 0.129 | Transcription factor STAT6 inhibitor | 0.129 0.045 CID_128685 | CID_128685 | |
| 0.173 | 0.094 | 0.173 | Death-associated protein kinase 3 inhibitor | 0.165 0.101 CID_128685 | ||
| 0.086 | 0.008 | 0.086 | Guanylate cyclase stimulant | 0.043 0.032 CID_128685 | ||
| 0.19 | 0.112 | 0.194 | Peptidyltransferase inhibitor | 0.194 0.107 CID_128685 | CID_128685 | |
| 0.161 | 0.084 | 0.161 | Tyrosine kinase inhibitor | |||
| 0.1 | 0.023 | 0.1 | Transforming growth factor beta 3 antagonist | 0.082 0.057 CID_128685 | ||
| 0.119 | 0.043 | 0.119 | Insulin receptor antagonist | |||
| 0.125 | 0.051 | 0.125 | 5 Hydroxytryptamine 3A agonist | |||
| 0.109 | 0.036 | 0.109 | NADH dehydrogenase inhibitor | |||
| 0.098 | 0.025 | 0.098 | Adenosine A2a receptor antagonist | 0.063 0.042 CID_128685 | ||
| 0.105 | 0.033 | 0.105 | MAP kinase 11 inhibitor | 0.075 0.051 CID_128685 | ||
| 0.122 | 0.05 | 0.134 | Activin receptor-like kinase 4 inhibitor | 0.134 0.038 CID_128685 | CID_128685 | |
| 0.123 | 0.052 | 0.171 | Ferrochelatase inhibitor | 0.171 0.03 CID_128685 | CID_128685 | |
| 0.162 | 0.092 | 0.162 | TRKC antagonist | |||
| 0.108 | 0.039 | 0.108 | Histamine N-methyltransferase inhibitor | |||
| 0.094 | 0.025 | 0.094 | Toll-Like receptor 7 antagonist | |||
| 0.144 | 0.079 | 0.144 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.1 | 0.035 | 0.1 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.14 | 0.075 | 0.14 | Activin receptor-like kinase 2 inhibitor | |||
| 0.076 | 0.012 | 0.076 | Nicotinic acid receptor 1 agonist | 0.063 0.015 CID_128685 | ||
| 0.141 | 0.077 | 0.141 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.074 | 0.011 | 0.074 | Bromodomain-containing protein 3 inhibitor | 0.059 0.021 CID_128685 | ||
| 0.077 | 0.014 | 0.077 | H+/K+-transporting ATPase inhibitor | |||
| 0.143 | 0.081 | 0.143 | Cytidine deaminase inhibitor | 0.117 0.103 CID_128685 | ||
| 0.089 | 0.027 | 0.091 | Transforming growth factor antagonist | 0.091 0.026 CID_128685 | CID_128685 | |
| 0.085 | 0.024 | 0.085 | Phosphatidylinositol 3-kinase delta inhibitor | |||
| 0.095 | 0.034 | 0.095 | Caspase 7 inhibitor | 0.094 0.036 CID_128685 | ||
| 0.085 | 0.024 | 0.085 | Protein kinase C iota inhibitor | 0.061 0.039 CID_128685 | ||
| 0.279 | 0.218 | 0.394 | Caspase 9 stimulant | 0.394 0.114 CID_128685 | CID_128685 | |
| 0.097 | 0.038 | 0.097 | Phosphodiesterase 4D inhibitor | |||
| 0.062 | 0.005 | 0.075 | MAP3K5 inhibitor | 0.075 0.004 CID_128685 | CID_128685 | |
| 0.093 | 0.036 | 0.093 | Rho-associated kinase I inhibitor | 0.072 0.054 CID_128685 | ||
| 0.076 | 0.019 | 0.076 | mTOR inhibitor | 0.053 0.035 CID_128685 | ||
| 0.076 | 0.02 | 0.076 | Phosphodiesterase II inhibitor | 0.051 0.046 CID_128685 | ||
| 0.212 | 0.156 | 0.283 | Angiogenesis inhibitor | 0.283 0.101 CID_128685 | CID_128685 | |
| 0.075 | 0.02 | 0.075 | Toll-Like receptor 8 antagonist | |||
| 0.168 | 0.113 | 0.168 | EphB2 antagonist | 0.153 0.127 CID_128685 | ||
| 0.095 | 0.042 | 0.095 | Myeloperoxidase inhibitor | |||
| 0.127 | 0.075 | 0.127 | Toll-Like receptor antagonist | |||
| 0.08 | 0.028 | 0.08 | Potassium channel (ATP-sensitive) blocker | 0.067 0.046 CID_128685 | ||
| 0.079 | 0.029 | 0.079 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.107 | 0.057 | 0.107 | Adenylate kinase inhibitor | |||
| 0.093 | 0.045 | 0.093 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.068 | 0.019 | 0.068 | Phosphodiesterase 2A inhibitor | |||
| 0.059 | 0.011 | 0.115 | Delayed rectifier potassium channel activator | 0.115 0.004 CID_128685 | CID_128685 | |
| 0.059 | 0.011 | 0.115 | Potassium channel KCNQ activator | 0.115 0.004 CID_128685 | CID_128685 | |
| 0.088 | 0.041 | 0.088 | Focal adhesion kinase 1 inhibitor | 0.069 0.064 CID_128685 | ||
| 0.088 | 0.041 | 0.088 | Fibroblast growth factor 3 antagonist | |||
| 0.161 | 0.114 | 0.166 | Focal adhesion kinase 2 inhibitor | 0.166 0.106 CID_128685 | CID_128685 | |
| 0.081 | 0.035 | 0.081 | CDC7 inhibitor | |||
| 0.116 | 0.071 | 0.116 | Beta amyloid protein antagonist | |||
| 0.123 | 0.079 | 0.123 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.128 | 0.084 | 0.128 | Protein kinase C nu inhibitor | 0.126 0.086 CID_128685 | ||
| 0.096 | 0.052 | 0.166 | Potassium channel activator | 0.166 0.015 CID_128685 | CID_128685 | |
| 0.172 | 0.13 | 0.176 | 5 Hydroxytryptamine 3E antagonist | 0.176 0.116 CID_128685 | CID_128685 | |
| 0.071 | 0.03 | 0.071 | Argininosuccinate synthase inhibitor | |||
| 0.08 | 0.041 | 0.08 | Phosphodiesterase VI inhibitor | 0.08 0.041 CID_128685 | ||
| 0.145 | 0.107 | 0.145 | Tumour necrosis factor antagonist | |||
| 0.201 | 0.163 | 0.201 | Immunomodulator | |||
| 0.081 | 0.044 | 0.081 | Glutamate dehydrogenase inhibitor | |||
| 0.065 | 0.028 | 0.065 | GABA A receptor antagonist | 0.057 0.033 CID_128685 | ||
| 0.077 | 0.041 | 0.08 | Glutamate (mGluR group I) antagonist | 0.08 0.038 CID_128685 | CID_128685 | |
| 0.1 | 0.065 | 0.1 | Check point kinase 2 inhibitor | |||
| 0.058 | 0.024 | 0.058 | Glutamate (mGluR5) antagonist | 0.055 0.025 CID_128685 | ||
| 0.038 | 0.005 | 0.04 | Glucosylceramidase stimulant | 0.04 0.004 CID_128685 | CID_128685 | |
| 0.063 | 0.03 | 0.063 | GABA receptor antagonist | 0.054 0.038 CID_128685 | ||
| 0.09 | 0.058 | 0.09 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.119 | 0.086 | 0.119 | Lck kinase inhibitor | |||
| 0.063 | 0.032 | 0.063 | Phosphodiesterase 4C inhibitor | 0.057 0.037 CID_128685 | ||
| 0.132 | 0.101 | 0.132 | MAP kinase 3 inhibitor | |||
| 0.067 | 0.036 | 0.067 | Transcription factor RelA inhibitor | |||
| 0.047 | 0.016 | 0.047 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.273 | 0.242 | 0.284 | Antiinflammatory | 0.284 0.23 CID_128685 | CID_128685 | |
| 0.062 | 0.033 | 0.062 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.041 | 0.012 | 0.041 | ATR kinase inhibitor | |||
| 0.094 | 0.066 | 0.097 | Phosphodiesterase 6D inhibitor | 0.097 0.058 CID_128685 | CID_128685 | |
| 0.052 | 0.024 | 0.052 | Cytokine production stimulant | |||
| 0.039 | 0.011 | 0.039 | CDK4/cyclin D3 inhibitor | |||
| 0.063 | 0.035 | 0.063 | CDK4/cyclin D inhibitor | |||
| 0.046 | 0.019 | 0.046 | Glutamate (mGluR group II) antagonist | |||
| 0.05 | 0.023 | 0.05 | Phosphodiesterase 6C inhibitor | 0.046 0.032 CID_128685 | ||
| 0.115 | 0.088 | 0.141 | Cyclin-dependent kinase 7 inhibitor | 0.141 0.066 CID_128685 | CID_128685 | |
| 0.048 | 0.023 | 0.048 | Guanylate cyclase inhibitor | |||
| 0.062 | 0.038 | 0.062 | Adenosine A1 receptor antagonist | |||
| 0.052 | 0.028 | 0.052 | Histamine H4 receptor antagonist | |||
| 0.103 | 0.08 | 0.103 | Nav1.5 sodium channel blocker | |||
| 0.1 | 0.077 | 0.128 | Glycogen synthase kinase-3 beta inhibitor | 0.128 0.056 CID_128685 | CID_128685 | |
| 0.049 | 0.027 | 0.049 | Glutamate (mGluR5) agonist | 0.049 0.028 CID_128685 | ||
| 0.053 | 0.031 | 0.066 | Transforming growth factor beta 1 antagonist | 0.066 0.022 CID_128685 | CID_128685 | |
| 0.061 | 0.039 | 0.061 | Phosphodiesterase 1A inhibitor | |||
| 0.069 | 0.048 | 0.069 | Phosphofructokinase-1 inhibitor | |||
| 0.12 | 0.1 | 0.12 | Peroxidase inhibitor | |||
| 0.028 | 0.008 | 0.028 | Guanylate cyclase 1 stimulant | |||
| 0.112 | 0.091 | 0.112 | DNA repair enzyme inhibitor | |||
| 0.091 | 0.071 | 0.146 | MAP kinase 8 inhibitor | 0.146 0.031 CID_128685 | CID_128685 | |
| 0.034 | 0.015 | 0.034 | Glutamate (mGluR2) antagonist | |||
| 0.124 | 0.104 | 0.124 | Src kinase inhibitor | |||
| 0.122 | 0.102 | 0.139 | Aurora-C kinase inhibitor | 0.139 0.066 CID_128685 | CID_128685 | |
| 0.037 | 0.018 | 0.048 | Benzodiazepine receptor peripheral-type antagonist | 0.048 0.008 CID_128685 | CID_128685 | |
| 0.062 | 0.043 | 0.062 | Phosphodiesterase 1C inhibitor | 0.061 0.047 CID_128685 | ||
| 0.114 | 0.096 | 0.114 | Protein kinase (CK1) gamma inhibitor | |||
| 0.036 | 0.018 | 0.036 | Potassium channel small-conductance Ca-activated activator | |||
| 0.086 | 0.069 | 0.086 | Fibroblast growth factor 1 antagonist | |||
| 0.046 | 0.029 | 0.049 | Potassium channel small-conductance Ca-activated blocker | 0.049 0.026 CID_128685 | CID_128685 | |
| 0.081 | 0.063 | 0.081 | T cell inhibitor | |||
| 0.08 | 0.064 | 0.087 | Bcr-Abl kinase inhibitor | 0.087 0.055 CID_128685 | CID_128685 | |
| 0.097 | 0.081 | 0.097 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.026 | 0.011 | 0.026 | Phosphodiesterase 6A inhibitor | 0.023 0.016 CID_128685 | ||
| 0.063 | 0.049 | 0.063 | p38 MAP kinase inhibitor | |||
| 0.032 | 0.019 | 0.032 | Phosphodiesterase 6B inhibitor | |||
| 0.034 | 0.021 | 0.04 | Transforming growth factor beta 2 antagonist | 0.04 0.013 CID_128685 | CID_128685 | |
| 0.235 | 0.222 | 0.235 | Calcium channel L-type activator | |||
| 0.048 | 0.036 | 0.048 | Phosphodiesterase 4A inhibitor | |||
| 0.043 | 0.032 | 0.043 | Phosphodiesterase 3B inhibitor | |||
| 0.088 | 0.076 | 0.091 | UDP-glucose 4-epimerase inhibitor | 0.091 0.072 CID_128685 | CID_128685 | |
| 0.043 | 0.031 | 0.043 | Dihydrofolate reductase inhibitor | |||
| 0.046 | 0.035 | 0.064 | Benzodiazepine antagonist | 0.064 0.01 CID_128685 | CID_128685 | |
| 0.094 | 0.082 | 0.119 | Protein kinase (CK2) alpha inhibitor | 0.119 0.063 CID_128685 | CID_128685 | |
| 0.125 | 0.115 | 0.125 | GABA C receptor rho-2 antagonist | |||
| 0.062 | 0.052 | 0.08 | Vanilloid 1 antagonist | 0.08 0.036 CID_128685 | CID_128685 | |
| 0.038 | 0.029 | 0.038 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.023 | 0.014 | 0.023 | Adenosine kinase inhibitor | |||
| 0.108 | 0.1 | 0.108 | Sodium channel (voltage-gated) blocker | |||
| 0.094 | 0.085 | 0.129 | Glycogen synthase kinase-3 inhibitor | 0.129 0.055 CID_128685 | CID_128685 | |
| 0.024 | 0.016 | 0.024 | Phosphodiesterase 6G inhibitor | |||
| 0.024 | 0.016 | 0.024 | Phosphodiesterase 6H inhibitor | |||
| 0.044 | 0.037 | 0.045 | Glutamate (mGluR group I) agonist | 0.045 0.036 CID_128685 | CID_128685 | |
| 0.093 | 0.086 | 0.093 | GABA receptor agonist | |||
| 0.149 | 0.143 | 0.207 | Growth factor agonist | 0.207 0.057 CID_128685 | CID_128685 | |
| 0.086 | 0.079 | 0.113 | Interleukin 1 beta converting enzyme inhibitor | 0.113 0.042 CID_128685 | CID_128685 | |
| 0.029 | 0.024 | 0.029 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.084 | 0.079 | 0.084 | Glutamate release inhibitor | |||
| 0.129 | 0.125 | 0.129 | Ca2+-transporting ATPase inhibitor | |||
| 0.094 | 0.091 | 0.094 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.192 | 0.189 | 0.192 | Vasodilator, coronary | |||
| 0.08 | 0.077 | 0.08 | Phosphodiesterase I inhibitor | |||
| 0.026 | 0.025 | 0.026 | Purinergic P2Y15 antagonist | |||
| 0.119 | 0.117 | 0.119 | MAP3K9 inhibitor | |||
| 0.081 | 0.08 | 0.1 | Polo-like kinase-1 inhibitor | 0.1 0.046 CID_128685 | CID_128685 | |
| 0.036 | 0.035 | 0.057 | Smo receptor antagonist | 0.057 0.02 CID_128685 | CID_128685 | |
| 0.065 | 0.064 | 0.081 | Nav1.8 sodium channel blocker | 0.081 0.042 CID_128685 | CID_128685 | |
| 0.042 | 0.044 | 0.053 | Adenosine A2b receptor antagonist | 0.053 0.031 CID_128685 | CID_128685 | |
| 0.1 | 0.105 | 0.135 | Glycogen synthase kinase-3 alpha inhibitor | 0.135 0.076 CID_128685 | CID_128685 | |
| 0.072 | 0.081 | 0.075 | GABA A receptor agonist | 0.075 0.074 CID_128685 | CID_128685 | |
| 0.024 | 0.041 | 0.034 | Methionyl aminopeptidase 1 inhibitor | 0.034 0.019 CID_128685 | CID_128685 | |
| 0.054 | 0.072 | 0.088 | MAP kinase 14 inhibitor | 0.088 0.042 CID_128685 | CID_128685 | |
| 0.129 | 0.153 | 0.225 | Aryl hydrocarbon receptor agonist | 0.225 0.09 CID_128685 | CID_128685 | |
| 0.067 | 0.103 | 0.087 | Protein kinase (CK2) inhibitor | 0.087 0.076 CID_128685 | CID_128685 | |
| 0.125 | 0.162 | 0.158 | Anticonvulsant | 0.158 0.119 CID_128685 | CID_128685 | |
| 0.192 | 0.234 | 0.222 | DNA directed DNA polymerase inhibitor | 0.222 0.21 CID_128685 | CID_128685 | |
| 0.076 | 0.124 | 0.103 | Cyclin-dependent kinase inhibitor | 0.103 0.087 CID_128685 | CID_128685 | |
| 0.084 | 0.165 | 0.101 | Interleukin 2 antagonist | 0.101 0.088 CID_128685 | CID_128685 | |
| 0.058 | 0.139 | 0.151 | Cyclin-dependent kinase 5 inhibitor | 0.151 0.04 CID_128685 | CID_128685 | |
| 0.035 | 0.119 | 0.079 | Vanilloid antagonist | 0.079 0.048 CID_128685 | CID_128685 | |
| 0.132 | 0.216 | 0.208 | 5 Hydroxytryptamine 1E antagonist | 0.208 0.121 CID_128685 | CID_128685 | |
| 0.207 | 0.295 | 0.299 | 5 Hydroxytryptamine release inhibitor | 0.299 0.167 CID_128685 | CID_128685 | |
| 0.047 | 0.167 | 0.106 | Mediator release inhibitor | 0.106 0.062 CID_128685 | CID_128685 | |
| 0.061 | 0.195 | 0.135 | Alpha-N-acetylglucosaminidase inhibitor | 0.135 0.065 CID_128685 | CID_128685 | |
| 0.105 | 0.255 | 0.155 | Death-associated protein kinase 2 inhibitor | 0.155 0.094 CID_128685 | CID_128685 | |
| 0.04 | 0.201 | 0.094 | ErbB-3 antagonist | 0.094 0.046 CID_128685 | CID_128685 | |
| 0.132 | 0.294 | 0.234 | DNA polymerase beta inhibitor | 0.234 0.202 CID_128685 | CID_128685 | |
| 0.018 | 0.23 | 0.064 | Amidase inhibitor | 0.064 0.059 CID_128685 | CID_128685 | |
| 0.119 | 0.333 | 0.239 | Transcription factor inhibitor | 0.239 0.195 CID_128685 | CID_128685 | |
| 0.035 | 0.498 | 0.103 | CDK3/cyclin E inhibitor | 0.103 0.082 CID_128685 | CID_128685 | |
| 0.091 | 0.559 | 0.248 | Ca(v)3.3 blocker | 0.248 0.104 CID_128685 | CID_128685 | |
| 0.064 | 0.595 | 0.139 | Cyclin-dependent kinase 3 inhibitor | 0.139 0.125 CID_128685 | CID_128685 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |